Exane Derivatives’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $122K | Sell |
1,473
-416
| -22% | -$34.5K | 0.07% | 246 |
|
|
2022
Q1 | $146K | Sell |
1,889
-220
| -10% | -$17K | 0.04% | 407 |
|
|
2021
Q4 | $186K | Sell |
2,109
-667
| -24% | -$58.9K | 0.05% | 350 |
|
|
2021
Q3 | $215K | Sell |
2,776
-293
| -10% | -$22.6K | 0.05% | 370 |
|
|
2021
Q2 | $250K | Buy |
3,069
+233
| +8% | +$19K | 0.06% | 332 |
|
|
2021
Q1 | $214K | Buy |
2,836
+978
| +53% | +$73.8K | 0.06% | 281 |
|
|
2020
Q4 | $163K | Buy |
1,858
+1,130
| +155% | +$99.1K | 0.05% | 329 |
|
|
2020
Q3 | $55.4K | Hold |
728
| – | – | 0.02% | 352 |
|
|
2020
Q2 | $89.8K | Hold |
728
| – | – | 0.02% | 293 |
|
|
2020
Q1 | $61.5K | Sell |
728
-165
| -18% | -$13.9K | 0.02% | 322 |
|
|
2019
Q4 | $79.3K | Hold |
893
| – | – | 0.01% | 323 |
|
|
2019
Q3 | $60.2K | Sell |
893
-5
| -0.6% | -$337 | 0.01% | 341 |
|
|
2019
Q2 | $76.9K | Buy |
898
+1
| +0.1% | +$86 | 0.01% | 342 |
|
|
2019
Q1 | $79.7K | Buy |
897
+430
| +92% | +$38.2K | 0.02% | 301 |
|
|
2018
Q4 | $39.8K | Buy |
467
+454
| +3,492% | +$38.6K | 0.01% | 350 |
|
|
2018
Q3 | $1.26K | Sell |
13
-1,315
| -99% | -$127K | ﹤0.01% | 484 |
|
|
2018
Q2 | $125K | Sell |
1,328
-35
| -3% | -$3.3K | 0.02% | 284 |
|
|
2018
Q1 | $108K | Buy |
1,363
+1,331
| +4,159% | +$106K | 0.02% | 278 |
|
|
2017
Q4 | $2.85K | Sell |
32
-140
| -81% | -$12.5K | ﹤0.01% | 401 |
|
|
2017
Q3 | $16K | Buy |
+172
| New | +$16K | ﹤0.01% | 328 |
|